Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNMX

Aevi Genomic Medicine (GNMX) Stock Price, News & Analysis

Aevi Genomic Medicine logo

About Aevi Genomic Medicine Stock (NASDAQ:GNMX)

Advanced Chart

Key Stats

Today's Range
$0.15
$0.18
50-Day Range
$0.17
$0.19
52-Week Range
$0.11
$0.35
Volume
2.95 million shs
Average Volume
3.16 million shs
Market Capitalization
$12.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aevi Genomic Medicine and its competitors with MarketBeat's FREE daily newsletter.

GNMX Stock News Headlines

Plc Astrazeneca's Net Worth
Aevi Genomic Medicine, Inc.
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
See More Headlines

GNMX Stock Analysis - Frequently Asked Questions

Aevi Genomic Medicine, LLC (NASDAQ:GNMX) announced its earnings results on Thursday, November, 1st. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aevi Genomic Medicine investors own include Inovio Pharmaceuticals (INO), Novavax (NVAX), SCYNEXIS (SCYX), Protalix BioTherapeutics (PLX), iBio (IBIO), Immunomedics (IMMU) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/01/2018
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GNMX
Previous Symbol
NASDAQ:MDGN
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.77 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.12 per share
Price / Book
1.38

Miscellaneous

Free Float
N/A
Market Cap
$12.89 million
Optionable
Optionable
Beta
1.13
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:GNMX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners